An immunotherapy drug recently-approved for a blood cancer called multiple myeloma can help produce even better results if it is administered during the early stages of the disease. These are the findings of a new study conducted by a team of researchers from the University of Torino in Italy.
Those who work as manicurists and pedicurists face a number of health problems, according to a new study.
